Expert sheds light on medical breakthroughs in obesity treatment

Expert sheds light on medical breakthroughs in obesity treatment

A worldwide health crisis now threatens individuals from all age brackets, thanks to the rise of obesity as a pandemic. The medical condition results when accumulated body fat exceeds safe levels, creating health risks from type 2 diabetes to heart disease, arthritis to fatty liver disease, and certain cancers. The severity of obesity grows because people lead slower lives while consuming more highly processed foods and face financial obstacles to adopting healthy behaviours.

Dr. Nanda Rajneesh, General and Laparoscopic Surgeon, FACRSI, FICS, MRCS, FAMS, Apollo Spectra Hospital, Bangalore, explains that medical researchers have developed new ways of fighting obesity at a time when the need to reduce obesity rates is increasing. Weight management solutions of today reflect medical developments that work against obesity. The article discusses current medical discoveries that present new possibilities for dealing with one of our generation's most critical health issues.

GLP-1 Receptor Agonists (e.g., Semaglutide, Tirzepatide)

Obesity medicine practices have undergone substantial changes because of new therapeutic agent innovations that have appeared in the last few years. GLP-1 RAs represent new obesity medications that include semaglutide together with the older medication liraglutide and the recently authorised tirzepatide, a dual GLP-1/GIP RAs agonist. The drugs successfully decrease body weight because this method produces effective results in obesity treatment. The medications aid weight reduction while improving blood lipid status and blood sugar levels, together with the belly obesity assessments.

Dual and Triple Hormone therapies (e.g., Amycretin)

The compound amycretin functions as both a GLP-1 receptor activator and an amylin receptor activator. The two-step action mode of this molecule directs its effects to appetite controls and metabolic processes to provide potential weight management benefits. The pharmaceutical company Novo Nordisk conducts clinical trials for amylincretin, which exists as an oral and subcutaneous medication.

Read More Agra Air Pollution: AQI Crosses 400 as Hospitals See Surge in Patients

Oral GLP-1 Receptor Agonists (e.g., Aleniglipron)

The GLP-1 receptor agonist aleniglipron (GSBR-1290) comes in an oral form from Structure Therapeutics. The Phase 2a obesity study showed that aleniglipron produced meaningful and statistically significant weight reduction while maintaining safe operation and tolerability patterns.

Read More Arwal Health Centres in Limbo as Land Shortage Delays Construction of Seven Facilities

Amylin Analogue Therapies

The hormone amylin controls both appetite and blood sugar regulation functions. The licensing agreement between AbbVie and Gubra involves GUB014295, which targets amylin to treat obesity. Initial Phase 1 testing verified that patients lost an average of 3 percent of their body weight.

Read More Thane Government Schools, Hospitals to Get ₹550 Crore Makeover by January 2028

Bariatric Surgery Innovations

Bariatric surgery stands as a highly efficient medical intervention for people who suffer from serious obesity. Patients sometimes develop post-bariatric hypoglycemia (PBH), which produces intense hypoglycemic episodes, likely after this medical procedure. The advancement of medical research aims to meet this unmet medical need, and Amylyx Pharmaceuticals, among other companies, contributes to this effort through therapeutic development.

Gut-Brain Axis Modulation

Experts state that signalling modification between the brain and gut shows potential for regulating metabolic function and hunger-related responses. Research has found that a newly developed compound has demonstrated promising results regarding weight loss and appetite reduction in laboratory animals by activating GLP-1 and leptin receptors simultaneously.

Conclusion: The Future of Obesity Treatment

Medical research, along with gene studies and pharmaceutical progress, is speeding up obesity treatment approaches. Science continues to advance toward success but requires a combination of medical developments, healthier life choices, and improved policy and healthcare support. The big question remains: Are we on the brink of curing obesity for good? The answer may be closer than we think.

Tags:

About The Author

Aryan Age Picture

Welcome to Aryan Age, an English newspaper that has been serving readers since 2011 from Delhi. With a loyal circulation of over 19,000, we are dedicated to providing our readers with the latest news and information, as well as insightful analysis and commentary that help them navigate the complex and rapidly changing world.

Post Comment

Comment List

Latest News

Beed Wife Murder: Husband Kills 55-Year-Old Woman Over Alleged Affair Dispute Beed Wife Murder: Husband Kills 55-Year-Old Woman Over Alleged Affair Dispute
Beed wife murder case: A 55-year-old woman was allegedly killed by her husband in Anandwadi after opposing his extramarital relationship....
Hathras Police Arrest Three in Shop Theft Case, Recover Cash and Jewellery Worth 962 Grams
Newlywed Woman Found Dead in Bihar's Saran, Family Alleges Strangulation

Live Cricket Score

Advertisement

Science & Tech

GTA 6 Launch Fever: Gamers Take Leave, Millions Preorder as Hype Peaks GTA 6 Launch Fever: Gamers Take Leave, Millions Preorder as Hype Peaks
GTA 6 is creating unprecedented excitement as millions preorder the game, employees plan time off and fans make personal arrangements...
India's October 2026 Car Sales: Kia Overtakes Toyota to Enter Top Five

Health

Sewage Surveillance: India Sets 48-Hour Reporting Rule to Detect Disease Outbreaks Early Sewage Surveillance: India Sets 48-Hour Reporting Rule to Detect Disease Outbreaks Early
India's new sewage surveillance guidelines mandate laboratories to report findings within 48 hours, enabling authorities to detect viruses, bacteria and...
Thane Government Schools, Hospitals to Get ₹550 Crore Makeover by January 2028

Lifestyle

Late-Night Mobile Scrolling: How Endless Reels Are Stealing Your Sleep Late-Night Mobile Scrolling: How Endless Reels Are Stealing Your Sleep
Late-night mobile scrolling and endless reels can disrupt sleep, affect fitness and increase food cravings. Find out why social media...
Princess Kate Stuns in Rs 70,000 Anarkali and Queen Elizabeth's Emerald Jewellery
crossorigin="anonymous">